[Retracted] Efficacy and Safety of Tripterygium Wilfordii Glycoside Tablets Combined with Acitretin Capsules in the Treatment of Moderate to Severe Plaque Psoriasis: A Randomized Controlled Trial

Table 1

General information of the patients in the three groups.

	Group A	Group B	Group C
Age (years)				0.963
Gender				0.717
Male	7	6	5
Female	5	6	7
Height (cm)				0.989
Weight (kg)				0.981
Age of onset (years)				0.995
Course of disease (years)				0.509
Location of skin lesion				0.945
Head and neck	2	1	1
Trunk	8	8	8
Limb	2	3	3
Extent coverage by skin lesion				0.929
<30%	1	1	1
31%-50%	5	4	6
51%-70%	3	5	4
>71%	3	2	1
Complications				0.793
Related to psoriasis	10	11	10
Not related to psoriasis	2	1	2
TG (mmol\L)				0.985
TC (mmol\L)				0.962
HDL-c (mmol\L)				0.993
LDL-c (mmol\L)				0.969
WBC (×10^9/L)				0.991
Platelet (×10^9/L)				0.997

Data was or . Group A, TWG tablets + acitretin capsules; Group B, compound glycyrrhizin capsules + acitretin capsules; Group C, acitretin capsules alone. TG: triglyceride; TC: total cholesterol; HDL-c: high-density lipoprotein cholesterol; LDL-c: low-density lipoprotein cholesterol; WBC: white blood cell count.